JPMF US Select Equity

Following a period of poor performance JPMorgan Fleming revamped the investment process of the JPMF US Select Equity fund earlier this year. It is, however, too early to pass judgment on the change.

Niklas Tell, 26 November, 2004 | 5:11PM
Facebook Twitter LinkedIn
The fund, a sub-fund of the Luxembourg-domiciled JPMorgan Fleming Investment Funds SICAV, was launched in 1984. It has lagged its peers in the North America Equity category in recent years as indicated by its two-star Morningstar Rating. Looking over five years the fund just makes a second quartile ranking. It has lost 7.13%, in sterling terms, on a five-year annualised basis as of November 24th.

Therefore it was not a surprise to see some changes being implemented earlier this year. The fund was previously run by the private banking arm of JPMF in America. Since February the fund has been modelled on a US-domiciled fund which has been available since 1997 – the US Analyst Portfolio. This means that the management of the fund was shifted to a team of senior institutional analyst

s. This team of 20 follow about 700 American companies.

The analysts follow an investment process in which they are aiming to generate outperformance by picking the right shares rather than taking bets on a sector level. The fund has remained a core American equity fund with a bias towards larger companies. Some 89% of assets were invested in large companies as of the latest portfolio made available to Morningstar.

It is well diversified across different sectors. Risk is also controlled on individual holdings as they must stay within four percentage points of the benchmark weight. It is too early to pass judgment on this fund as the new process has been in place for less than a year. Investors will need to wait to see if these changes improve the bottom line.

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

About Author

 

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures